Questions people ask about MTHFR Senioren

MTHFR variants (e.g., rs1801133, C677T) are common and affect the conversion of folic acid to its active form, methylfolate. In seniors, elevated homocysteine levels are often observed, which are associated with cardiovascular and cognitive risks. However, the evidence for a causal link or clear benefit from supplementation with methylfolate or vitamin B12 is mixed. Randomized trials have not consistently shown a reduction in heart attacks or strokes through homocysteine-lowering interventions. Moreover, the effects of individual variants are small and heavily influenced by diet, lifestyle, and other genetic factors. Direct-to-consumer tests like MyBody-X can detect these variants, but the clinical actionability for seniors without medical guidance is unclear. Routine supplementation is not recommended; instead, homocysteine levels should be measured and discussed with a physician. The overall evidence is mixed—mechanistic and observational studies exist, but no strong clinical guideline supports intervention based solely on MTHFR status in seniors.